Krystal Biotech

KRYS

NASDAQHealth Care

Income Statement

Total Revenue$290.51M

Gross Profit$270.45M

Operating Income$65.73M

EBITDA$102.07M

EBIT$95.36M

Pre-tax Income$189.47M

Net Income$89.16M

Cash Equivalent$355.91M

Total Debt$7.58M

Book Value$867.59M

Book Value Per Share30.35

Return on Equity (ROE)+9.42%

Return on Assets (ROA)+8.44%

Return on Invested Capital (ROI)+9.42%

Net Profit Margin+30.69%

Current Ratio7.28

Quick Ratio6.89

Long-Term Debt / Equity0.00